1989
DOI: 10.1016/0223-5234(89)90076-7
|View full text |Cite
|
Sign up to set email alerts
|

Synthèse des diastéréoisomères 1,2-bis(2-,3- et 4-fluorophényl)éthylènediamines 4–6, 10–12 à partir de méso 1,2-bis(2-hydroxyphényl)éthylènediamine et de 2-,3- et 4-fluorobenzaldéhyde par la transposition de diaza-Cope et leur transformation en complexes [1,2-bis(2-,3- et 4-fluorophényl)éthylènediamine]dihaloplatine (II) (Hal = Cl: 13–18; Hal = I: 19–24) à l'aide de K2PtHaI4

Abstract: The synthesis of the diastereomeric 1,2-bis(2-,3-and 4-fluorophenyl)ethylenediamines 4-6, lo-12 from meso-1,2-bis(2-hydroxyphenyl)ethylenediamine and 2-, 3-and 4-fluorobenzaldehyde by a diaza-Cope-rearrangement and their conversion into the [1,2-bis(2-, 3-and 4-fluorophenyl)ethylenediamine]dihaloplatinum (II) complexes (Hal = Cl, 13-M; Hal = I, 19-24) with K,PtHal, is described. From the diiodoplatinum(I1) complexes (19-24) the better water soluble diaqua[l,Zbis(2-, 3-and 4-fluorophenyl)ethylenediamine]platinu… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

1990
1990
2006
2006

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 23 publications
(2 citation statements)
references
References 7 publications
0
2
0
Order By: Relevance
“…First hints to this mode of action of [1,2-diarylethylenediamine]platinum(II) complexes, with which we have thoroughly investigated the influence of substituents in the aromatic rings on their antitumor activity, ,,, , came from a study with [ meso -1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]platinum(II) ( meso -6-PtLL ‘), [ meso - and [ d,l -1,2-bis(4-fluorophenyl)ethylendiamine]platinum(II) ( meso - and d , l -8-PtLL ‘) and cisplatin (cDDP) . In experiments on the human MCF-7 breast cancer cell line, the rate of complexation with DNA followed the order d , l -8-PtLL ‘ > cDDP > meso -8-PtLL ‘ > meso -6-PtLL ‘.…”
Section: Discussionmentioning
confidence: 99%
“…First hints to this mode of action of [1,2-diarylethylenediamine]platinum(II) complexes, with which we have thoroughly investigated the influence of substituents in the aromatic rings on their antitumor activity, ,,, , came from a study with [ meso -1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]platinum(II) ( meso -6-PtLL ‘), [ meso - and [ d,l -1,2-bis(4-fluorophenyl)ethylendiamine]platinum(II) ( meso - and d , l -8-PtLL ‘) and cisplatin (cDDP) . In experiments on the human MCF-7 breast cancer cell line, the rate of complexation with DNA followed the order d , l -8-PtLL ‘ > cDDP > meso -8-PtLL ‘ > meso -6-PtLL ‘.…”
Section: Discussionmentioning
confidence: 99%
“…Remarkable activity of polynuclear compounds was noticed in a wide panel of tumor cells, but for breast cancer cell lines, especially the MCF-7 cell line, a relatively low activity was found. , Therefore, we focused our attention to the design of drugs with increased selectivity for breast tumors. In this initial study, we combined the well-known [1,2-bis(4-fluorophenyl)ethylenediamine]platinum(II) complex , with alkylamines, alkyldiamines, and the DAB(PA) 4 polyimine dendrimer. We studied the significance of the charge and the alkyl chain length of the molecules on their cytotoxicity, the cellular uptake, the nuclear content, the binding to DNA in cells, and the binding characteristics to human serum albumin (HSA).…”
Section: Introductionmentioning
confidence: 99%